BioVaxys Technology (TSE:BIOV) has released an update.
BioVaxys Technology Corp. has successfully had the cease trade order, originally issued due to a delay in their financial filings, revoked by the Ontario Securities Commission as of July 11, 2024. The company has now completed all the required filings, which are accessible on SEDAR+. This revocation marks a positive regulatory milestone for BioVaxys, potentially reinstating investor confidence.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
